Chronic performance of an active fixation coronary sinus lead

George H. Crossley, Derek Exner, R. Hardwin Mead, Robert A Sorrentino, Robert Hokanson, Shelby Li, Stuart Adler

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in appropriately selected patients with heart failure. Optimal left ventricular (LV) lead placement is useful in enhancing response from CRT. Three significant obstacles to LV lead placement are patient-specific variations in coronary venous anatomy, phrenic nerve stimulation, and a significant rate of LV lead dislodgement or microdislodgement. Objective: The primary objective of this study was to determine the safety and effectiveness of the Medtronic StarFix active fixation LV lead. Secondary objectives evaluated implant success, lead placement and procedure time, lead handling and lobe deployment, additional electrical performance, and all adverse events reported in the study. Methods: There were 441 patients enrolled in this multicenter study. Standard cardiac resynchronization therapy (CRT) inclusion criteria were used. Patients were followed up for a mean of 23 months. Implant data, success with CRT, LV lead performance, clinical outcomes, and experience with LV lead revisions were prospectively evaluated. Results: The mean LV stimulation threshold at implant was 1.3 ± 1 volts and was stable over time. Sensing was also excellent. In 96.3% of the implantations in this study, the physician was able to place the lead in a nonanterior position. Extracardiac (phrenic nerve) stimulation required invasive intervention in 11 subjects (2.5%). Only 3 dislodgements (0.7%) were observed. Two occurred in the first 5 implants and were attributed to inadequate engagement of the venous subbranch. Conclusion: The Medtronic 4195 is safe and highly efficacious. It affords the physician more choices in lead placement location and has a remarkably low dislodgement rate.

Original languageEnglish (US)
Pages (from-to)472-478
Number of pages7
JournalHeart Rhythm
Volume7
Issue number4
DOIs
StatePublished - Apr 1 2010

Fingerprint

Coronary Sinus
Cardiac Resynchronization Therapy
Phrenic Nerve
Physicians
Lead
Multicenter Studies
Anatomy
Heart Failure
Morbidity
Safety
Mortality

Keywords

  • Active fixation
  • Cardiac resynchronization therapy
  • Coronary sinus lead
  • Implantable cardioverter defibrillator
  • Lead dislodgement
  • Lead extraction
  • Lead revision
  • Left ventricular lead

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Crossley, G. H., Exner, D., Mead, R. H., Sorrentino, R. A., Hokanson, R., Li, S., & Adler, S. (2010). Chronic performance of an active fixation coronary sinus lead. Heart Rhythm, 7(4), 472-478. https://doi.org/10.1016/j.hrthm.2010.01.007

Chronic performance of an active fixation coronary sinus lead. / Crossley, George H.; Exner, Derek; Mead, R. Hardwin; Sorrentino, Robert A; Hokanson, Robert; Li, Shelby; Adler, Stuart.

In: Heart Rhythm, Vol. 7, No. 4, 01.04.2010, p. 472-478.

Research output: Contribution to journalArticle

Crossley, GH, Exner, D, Mead, RH, Sorrentino, RA, Hokanson, R, Li, S & Adler, S 2010, 'Chronic performance of an active fixation coronary sinus lead', Heart Rhythm, vol. 7, no. 4, pp. 472-478. https://doi.org/10.1016/j.hrthm.2010.01.007
Crossley, George H. ; Exner, Derek ; Mead, R. Hardwin ; Sorrentino, Robert A ; Hokanson, Robert ; Li, Shelby ; Adler, Stuart. / Chronic performance of an active fixation coronary sinus lead. In: Heart Rhythm. 2010 ; Vol. 7, No. 4. pp. 472-478.
@article{afa24d3902294405969d21b362884f2a,
title = "Chronic performance of an active fixation coronary sinus lead",
abstract = "Background: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in appropriately selected patients with heart failure. Optimal left ventricular (LV) lead placement is useful in enhancing response from CRT. Three significant obstacles to LV lead placement are patient-specific variations in coronary venous anatomy, phrenic nerve stimulation, and a significant rate of LV lead dislodgement or microdislodgement. Objective: The primary objective of this study was to determine the safety and effectiveness of the Medtronic StarFix active fixation LV lead. Secondary objectives evaluated implant success, lead placement and procedure time, lead handling and lobe deployment, additional electrical performance, and all adverse events reported in the study. Methods: There were 441 patients enrolled in this multicenter study. Standard cardiac resynchronization therapy (CRT) inclusion criteria were used. Patients were followed up for a mean of 23 months. Implant data, success with CRT, LV lead performance, clinical outcomes, and experience with LV lead revisions were prospectively evaluated. Results: The mean LV stimulation threshold at implant was 1.3 ± 1 volts and was stable over time. Sensing was also excellent. In 96.3{\%} of the implantations in this study, the physician was able to place the lead in a nonanterior position. Extracardiac (phrenic nerve) stimulation required invasive intervention in 11 subjects (2.5{\%}). Only 3 dislodgements (0.7{\%}) were observed. Two occurred in the first 5 implants and were attributed to inadequate engagement of the venous subbranch. Conclusion: The Medtronic 4195 is safe and highly efficacious. It affords the physician more choices in lead placement location and has a remarkably low dislodgement rate.",
keywords = "Active fixation, Cardiac resynchronization therapy, Coronary sinus lead, Implantable cardioverter defibrillator, Lead dislodgement, Lead extraction, Lead revision, Left ventricular lead",
author = "Crossley, {George H.} and Derek Exner and Mead, {R. Hardwin} and Sorrentino, {Robert A} and Robert Hokanson and Shelby Li and Stuart Adler",
year = "2010",
month = "4",
day = "1",
doi = "10.1016/j.hrthm.2010.01.007",
language = "English (US)",
volume = "7",
pages = "472--478",
journal = "Heart Rhythm",
issn = "1547-5271",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Chronic performance of an active fixation coronary sinus lead

AU - Crossley, George H.

AU - Exner, Derek

AU - Mead, R. Hardwin

AU - Sorrentino, Robert A

AU - Hokanson, Robert

AU - Li, Shelby

AU - Adler, Stuart

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Background: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in appropriately selected patients with heart failure. Optimal left ventricular (LV) lead placement is useful in enhancing response from CRT. Three significant obstacles to LV lead placement are patient-specific variations in coronary venous anatomy, phrenic nerve stimulation, and a significant rate of LV lead dislodgement or microdislodgement. Objective: The primary objective of this study was to determine the safety and effectiveness of the Medtronic StarFix active fixation LV lead. Secondary objectives evaluated implant success, lead placement and procedure time, lead handling and lobe deployment, additional electrical performance, and all adverse events reported in the study. Methods: There were 441 patients enrolled in this multicenter study. Standard cardiac resynchronization therapy (CRT) inclusion criteria were used. Patients were followed up for a mean of 23 months. Implant data, success with CRT, LV lead performance, clinical outcomes, and experience with LV lead revisions were prospectively evaluated. Results: The mean LV stimulation threshold at implant was 1.3 ± 1 volts and was stable over time. Sensing was also excellent. In 96.3% of the implantations in this study, the physician was able to place the lead in a nonanterior position. Extracardiac (phrenic nerve) stimulation required invasive intervention in 11 subjects (2.5%). Only 3 dislodgements (0.7%) were observed. Two occurred in the first 5 implants and were attributed to inadequate engagement of the venous subbranch. Conclusion: The Medtronic 4195 is safe and highly efficacious. It affords the physician more choices in lead placement location and has a remarkably low dislodgement rate.

AB - Background: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in appropriately selected patients with heart failure. Optimal left ventricular (LV) lead placement is useful in enhancing response from CRT. Three significant obstacles to LV lead placement are patient-specific variations in coronary venous anatomy, phrenic nerve stimulation, and a significant rate of LV lead dislodgement or microdislodgement. Objective: The primary objective of this study was to determine the safety and effectiveness of the Medtronic StarFix active fixation LV lead. Secondary objectives evaluated implant success, lead placement and procedure time, lead handling and lobe deployment, additional electrical performance, and all adverse events reported in the study. Methods: There were 441 patients enrolled in this multicenter study. Standard cardiac resynchronization therapy (CRT) inclusion criteria were used. Patients were followed up for a mean of 23 months. Implant data, success with CRT, LV lead performance, clinical outcomes, and experience with LV lead revisions were prospectively evaluated. Results: The mean LV stimulation threshold at implant was 1.3 ± 1 volts and was stable over time. Sensing was also excellent. In 96.3% of the implantations in this study, the physician was able to place the lead in a nonanterior position. Extracardiac (phrenic nerve) stimulation required invasive intervention in 11 subjects (2.5%). Only 3 dislodgements (0.7%) were observed. Two occurred in the first 5 implants and were attributed to inadequate engagement of the venous subbranch. Conclusion: The Medtronic 4195 is safe and highly efficacious. It affords the physician more choices in lead placement location and has a remarkably low dislodgement rate.

KW - Active fixation

KW - Cardiac resynchronization therapy

KW - Coronary sinus lead

KW - Implantable cardioverter defibrillator

KW - Lead dislodgement

KW - Lead extraction

KW - Lead revision

KW - Left ventricular lead

UR - http://www.scopus.com/inward/record.url?scp=77949484911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949484911&partnerID=8YFLogxK

U2 - 10.1016/j.hrthm.2010.01.007

DO - 10.1016/j.hrthm.2010.01.007

M3 - Article

VL - 7

SP - 472

EP - 478

JO - Heart Rhythm

JF - Heart Rhythm

SN - 1547-5271

IS - 4

ER -